Mark Perrin

Experience

• 

  Lederle Laboratories

  Jan 1979 - Jan 1992

  Vice President and General Manager, U.S. Pharmaceuticals

  Increasingly responsible positions, including:• Vice President and General Manager – U.S. PharmaceuticalsReporting to President, headed all commercial operations in the U.S., directing staff of 1,200.• Vice President and General Manager – U.S. Consumer Health Products • Director, Commercial Operations – Lederle Vaccines and Biologicals• Division Manager – Lederle Canada

• 

  Burroughs Wellcome Company

  Jan 1992 - Jan 1995

  Vice President, U.S. Sales and Marketing

  Reported to President and headed all commercial operations in the U.S., directing staff of 1,070. • New product launch experience: Lamictal® (anti-epileptic), Valtrex® (antiviral), Wellbutrin SR® (anti-depressant), and Navelbine® (anticancer).• Successfully restaged company’s flagship product, the antiviral Zovirax®. • Managed commercial, policy, and patient advocacy issues related to AZT (Retrovir®), industry’s first anti-HIV product.• Established company’s first dedicated Oncology/HIV sales force. Show less

• 

  COR Therapeutics

  Jan 1995 - Jan 2001

  Executive Vice President, Commercial Operations

  Created and developed sales, marketing, and manufacturing functions for emerging biotech company. Built 100-person hospital-based sales force (including supporting infrastructure) and comprehensive marketing department. Key involvement with company financings, FDA negotiations, partnership negotiations, R&D portfolio rationalization, product acquisitions, and corporate strategy development.• Captured #1 market share over competitive Lilly and Merck products for company’s first commercial product, Integrilin®, indicated for acute coronary syndrome and percutaneous coronary intervention.• Shareholder value increased more than tenfold as a result of the success of Integrilin®. Show less

• 

  Orphan Medical

  Jan 2002 - Jan 2005

  Executive Vice President and Chief Commercial Officer

  Specialty pharm company focused on drug development for orphan diseases, principally sleep disorders and specialty CNS therapeutic areas. Directed sales, marketing, business development, distribution, and international functions. The newly established specialty commercial organization contributed significantly to overall corporate valuation.• Built CNS specialty sales force and supporting infrastructure. Directed all commercial activities for launch of company’s first major commercial product, Xyrem®, for the treatment of narcolepsy (current sales ~$1.6 billion).• Spearheaded effort in sale of company to Jazz Pharmaceuticals. Show less

• 

  ConjuChem Biotechnologies

  Jan 2005 - Jan 2010

  President & Chief Executive Officer

  Led and directed staff of public (TSX) company developing long-acting conjugated peptide therapeutics representing multi-billion-dollar market potential. Recruited key members of leadership team.• Raised $158 million in new equity and debt financing. • Advanced the lead clinical program (a GLP-1 agonist) for diabetes with $1+ billion market potential to Phase IIb.

• 

  Dennan Consulting

  Jan 2011 - Jan 2013

  President

  Provided consulting to key biotech/healthcare executives, focusing primarily on organizational dynamics and team leadership. Also provided consulting services to emerging life sciences company regarding development of overall commercialization plans.

• 

  InVivo Therapeutics

  Jan 2014 - Dec 2017

  Chief Executive Officer and Chairman

  Employing commercialization and operational expertise, responsibilities focused on identifying and resourcing high-value opportunities to leverage the company’s novel technology from Dr. Robert Langer’s MIT lab for portfolio development and critical resource deployment.• Raised $64 million via follow-on financings and uplisted company to Nasdaq.• Initiated company’s first in-human clinical trial of its novel Neuro-Spinal Scaffold™ in acute spinal cord injury (SCI). • Built the leadership team with the addition of chief scientific officer, general counsel, chief medical officer, chief commercial officer, and new chief financial officer. Show less

• 

  Keystone Partners

  Mar 2020 - Feb 2021

  Executive Coach

  Keystone Partners Leadership Development (KPLD) Group provides exceptional and sustainable executive coaching and leadership development solutions to create business advantage. KPLD serves as a catalyst for developing talent and creating value, offering a range of services, including executive coaching, leadership development, training, and team effectiveness programs.

• 

  PERRIN & ASSOCIATES

  Jun 2020 - now

  Founder and CEO

  A new and different human capital strategy firm committed to helping others see and experience new possibilities. My goal is to leverage my extensive career experiences, which has included public company CEO and board roles, to the field of executive leadership coaching. My corporate background, along with my coaching process and executive coaching style, can support CEOs, C-suite/senior executives, and board members to maximize their potential and to achieve both personal and professional success. Show less